Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
2(40%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
5
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution5 total trials
N/ANon-phased studies
5(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

5

all time

Status Distribution
Active(2)
Completed(3)

Detailed Status

Completed3
Recruiting1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
2
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A5 (100.0%)

Trials by Status

completed360%
recruiting120%
active_not_recruiting120%

Recent Activity

2 active trials
Showing 5 of 5
active_not_recruitingnot_applicable

Social Risk Factors and Discrimination in Cancer Survivorship

NCT05301114
recruitingnot_applicable

Philly CEAL- DECIDE+ Adaptation

NCT06732102
completednot_applicable

Community Health Workers and Precision Medicine

NCT04843332
completednot_applicable

Community Health Workers Against COVID19

NCT04426305
completednot_applicable

Home-Based Asthma Support and Education for Adults

NCT01783028

Clinical Trials (5)

Showing 5 of 5 trials
NCT05301114Not Applicable

Social Risk Factors and Discrimination in Cancer Survivorship

Active Not Recruiting
NCT06732102Not Applicable

Philly CEAL- DECIDE+ Adaptation

Recruiting
NCT04843332Not Applicable

Community Health Workers and Precision Medicine

Completed
NCT04426305Not Applicable

Community Health Workers Against COVID19

Completed
NCT01783028Not Applicable

Home-Based Asthma Support and Education for Adults

Completed

All 5 trials loaded

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
5